Device Invented by Local Physician Receives FDA Clearance
Liquet™ Medical Inc.’s Versus™ Catheter enables new treatment category for blood clots in the lungs
Dr. Patrick Kelly of Dakota Vascular
Virginia-based medical device company Liquet Medical Inc. has received 510(k) clearance from the U.S. Food and Drug Administration for its Versus™ Catheter, a device patented by Sanford Health and invented by vascular surgeon Patrick Kelly, MD, during his employment as a Sanford physician. Dr. Kelly is now with Dakota Vascular in Sioux Falls.
This device is set to enhance the treatment of pulmonary artery blood clots by offering real-time pulmonary artery pressure measurements, empowering clinicians to optimize treatment based on individual patient responses. This novel technology enables a new treatment category called “Hemodynamics-Led Thrombolysis (HLT).”
“As a physician, I saw an opportunity to create a solution that puts actionable, real-time data into the hands of clinicians, allowing them to optimize clot treatment and improve outcomes for patients,” said Dr. Kelly. “The Liquet Versus™ Catheter is a culmination of years of work, and I am thrilled to see it gain FDA clearance and enter the market where it can make a life-changing impact.”
“The Versus™ Catheter will allow for a more data-centric approach to each individual patient suffering from blood clots in the lungs,” said Luke Wilkins, M.D., Interventional Radiologist at UVA Health who will be working closely with the Versus™ Catheter. “Hemodynamic-led thrombolytic therapy is an opportunity to potentially improve patient outcomes, and we are looking forward to studying this device.”
Key Features and Benefits of the Versus™ Catheter:
Real-Time Pulmonary Artery Pressure Monitoring: Provides physicians live data to assess patient hemodynamics before and during therapy to optimize treatment decisions.
Dual-Tip Telescoping Catheter: Enables simultaneous treatment of both lungs with a single device, offering access site alternatives to the physician, and improving healthcare efficiency.
Flexible Placement: Standard guidewire technique or flow-directed balloon placement.
“FDA 510(k) clearance is a significant milestone for Liquet Medical and enables the commercial release of the Versus™ Catheter to hospitals and clinics across the U.S.,” said John Schindler, CEO of Liquet Medical. “We believe this innovation has the potential to significantly improve patient outcomes, minimize risks, and reduce healthcare costs.”